59 results
SC 13D/A
EX-2
Eastern Capital LTD
18 Jun 20
Marker Therapeutics / Eastern Capital ownership change
4:42pm
SC 13D/A
EX-2
Eastern Capital LTD
18 Jun 20
Marker Therapeutics / Eastern Capital ownership change
4:42pm
SC 13D/A
EX-2.2
MRKR
Marker Therapeutics Inc
20 Feb 20
Beneficial ownership report (amended)
4:24pm
SC 13D/A
EX-2.1
MRKR
Marker Therapeutics Inc
20 Feb 20
Beneficial ownership report (amended)
4:24pm
SC 13D/A
EX-2.3
MRKR
Marker Therapeutics Inc
20 Feb 20
Beneficial ownership report (amended)
4:24pm
SC 13D/A
EX-2.2
li34w 330xxc1hcty8e
8 Nov 18
Marker Therapeutics, Inc.
11:22am
SC 13D/A
EX-2.4
qc618 x00hcaekmm
8 Nov 18
Marker Therapeutics, Inc.
11:22am
SC 13D/A
EX-2.1
khyuqr9uvee
8 Nov 18
Marker Therapeutics, Inc.
11:22am
SC 13D/A
EX-2.3
1hebcpwgn7age6s7 on
8 Nov 18
Marker Therapeutics, Inc.
11:22am
SC 13D/A
EX-2
ws6y510
16 May 18
Tapimmune Inc.
5:14pm
SC 13D/A
EX-2
766rz8zu7jw1chftth0
16 May 18
Tapimmune Inc.
5:14pm
SC 13D/A
EX-2
yel5vv2 sqk
16 May 18
Tapimmune Inc.
5:14pm
SC 13D/A
EX-2
3w0hc9
16 May 18
Tapimmune Inc.
5:14pm
8-K
EX-2.1
vlzczoup2xrtpwyt217g
15 May 18
TapImmune and Marker Therapeutics Announce Entry into Merger Agreement, Creating a Transformational Immuno-Oncology Platform
6:07am
DEFA14A
EX-2.1
039nxfyf8hgclqb
15 May 18
Additional proxy soliciting materials
6:05am
SC 13D
EX-2.4
6eqq6ovjjc
25 Aug 17
Tapimmune Inc.
12:00am
SC 13D
EX-2.3
slnobkbliezg x2lc
25 Aug 17
Tapimmune Inc.
12:00am
SC 13D
EX-2.1
yed q416de2ph
25 Aug 17
Tapimmune Inc.
12:00am
SC 13D
EX-2.2
3mk6as2cly41rnq
25 Aug 17
Tapimmune Inc.
12:00am
SC 13D/A
EX-2
nhkqatm292
12 Aug 16
Tapimmune Inc
12:00am